HSP90AA1 and cancer: Since Hsp90 is critical for cell homeostasis and interacts with approximately 200 proteins, inhibitors developed to target the intracellular Hs90’s ATP-dependent chaperone function has encountered setbacks in cancer clinical trials due to high toxicity observed at effective doses likely due to interference with Hsp90’s function of homeostasis [5,6].